Date Filed | Type | Description |
06/09/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
06/02/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 4,000 shares
@ $0 Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns:
| Sold 20,000 shares
@ $8, valued at
$160k
|
|
09/19/2022 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
Granted 8,000 restricted stock units
@ $0 |
|
09/15/2022 |
4
| Young Richard A (Director) has filed a Form 4 on Omega Therapeutics, Inc.
Txns:
| Sold 10,000 shares
@ $8, valued at
$80k
|
|
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/10/2021 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 17,500 options to buy
@ $6.3, valued at
$110.3k
|
|
02/18/2021 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 3,750 shares
@ $12.05, valued at
$45.2k
|
|
02/10/2021 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 3,750 shares
@ $13.04, valued at
$48.9k
|
|
02/10/2021 |
4/A
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 633 shares
@ $8.98, valued at
$5.7k
Sold 5,357 shares
@ $8.75, valued at
$46.9k
|
|
11/18/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 633 shares
@ $8.98, valued at
$5.7k
Sold 5,357 shares
@ $8.75, valued at
$46.9k
|
|
10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 5,990 shares
@ $10.39, valued at
$62.2k
|
|
08/19/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 5,990 shares
@ $12.59, valued at
$75.4k
|
|
07/17/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 5,990 shares
@ $11.85, valued at
$71k
|
|
06/16/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 5,990 shares
@ $8.75, valued at
$52.4k
|
|
06/11/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 17,500 options to buy
@ $9.17, valued at
$160.5k
|
|
05/15/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 5,990 shares
@ $9.2224, valued at
$55.2k
|
|
04/17/2020 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 23,960 shares
@ $8.75, valued at
$209.7k
|
|
08/19/2019 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 2,300 shares
@ $10, valued at
$23k
Sold 22,700 shares
@ $10, valued at
$227k
|
|
06/12/2019 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 11,000 options to buy
@ $5.6, valued at
$61.6k
|
|
06/15/2018 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 11,000 options to buy
@ $12.95, valued at
$142.5k
|
|
09/22/2017 |
4/A
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 11,000 options to buy
@ $0 |
|
08/16/2017 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 3,282 shares
@ $22, valued at
$72.2k
|
|
07/27/2017 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Sold 3,282 shares
@ $22.0889, valued at
$72.5k
|
|
06/12/2017 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns:
| Granted 11,000 options to buy
@ $14.26, valued at
$156.9k
|
|
02/13/2017 |
5
| Young Richard A (Director) has filed a Form 5 on Syros Pharmaceuticals, Inc. |
09/19/2016 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
01/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/03/2012 |
4
| Young Richard A (Director) has filed a Form 4 on ENZON PHARMACEUTICALS INC
Txns:
| Granted 10,669 shares
@ $0 |
|
|